EUVIMEDEUVIMED entdecken
Crossref

The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul

Hale Zerrin Toklu, Meral Keyer Uysal

Pharmacy World & Science · 2008-10 · 30 (5) · 556-562

DOI: 10.1007/s11096-008-9209-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacy World & Science, online erschienen am 19.03.2008. Verfasst von Hale Zerrin Toklu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Marmara University School of Pharmacy, Tibbiye Cad. No: 49 Haydarpaşa, Istanbul, Turkey. haletoklu@yahoo.com. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Attitude of Health Personnel, Health Knowledge, Attitudes, Practice. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: We investigated the knowledge and attitudes of community pharmacists towards pharmacovigilance and adverse drug reactions (ADRs) in Kadiköy district of Istanbul (Turkey). SETTING: The community pharmacies in Kadikoy. Kadikoy is one of the biggest districts of Istanbul and has the largest number of pharmacies. Kadikoy district was divided into two regions, the central and the peripheral. METHOD: Between December 2005 and June 2006 we conducted a survey about the knowledge and attitude of community pharmacists (n = 219) using a face-to-face questionnaire. The questionnaire consisted of questions about the sociodemographic characteristics of the pharmacists, their knowledge of pharmacovigilance and their attitudes towards ADR reporting. MAIN OUTCOMES MEASURED: The knowledge of pharmacovigilance practice, ADR reporting compliance rates, reasons for not reporting ADR and perceptions of the Turkish community pharmacists on pharmacovigilance practice were evaluated. RESULTS: Although all 411 pharmacies in the Kadikoy district were visited, only 53% of the community pharmacists (n = 219) consented to participate in the study. Of those that did respond, only 17.2% of the pharmacists had any knowledge about 'pharmacovigilance'. Sixty-five percent of the pharmacists stated that patients reported an ADR to them during the previous 12 months, and 21% of pharmacists reported to the concerned organizations. Our survey showed that only 7% actually reported an ADR to the national pharmacovigilance center. On the other hand, 89% of the pharmacists believed that the role of the pharmacist in ADR reporting was essential. CONCLUSION: The results show that Turkish community pharmacists have poor knowledge about pharmacovigilance. There is an urgent need for educational programs to train them about pharmacovigilance and ADR reporting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adverse Drug Reaction Reporting SystemsAttitude of Health PersonnelHealth Knowledge, Attitudes, PracticeAdultCommunity Pharmacy ServicesEducation, PharmacyFemaleHumansMaleMiddle AgedPharmacistsProfessional RoleSurveys and QuestionnairesTurkeyYoung Adult

Autor:innen und Institutionen

  • Department of Pharmacology, Marmara University School of Pharmacy, Tibbiye Cad. No: 49 Haydarpaşa, Istanbul, Turkey. haletoklu@yahoo.com

Zitieren

APA

Toklu, H. Z., & Uysal, M. K. (2008). The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharmacy World & Science, 30(5), 556-562. https://doi.org/10.1007/s11096-008-9209-4

Vancouver

Toklu HZ, Uysal MK. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharmacy World & Science. 2008;30(5):556-562. doi:10.1007/s11096-008-9209-4

BibTeX
@article{Toklu2008,
  author = {Toklu, Hale Zerrin and Uysal, Meral Keyer},
  title = {The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul},
  journal = {Pharmacy World & Science},
  year = {2008},
  volume = {30},
  number = {5},
  pages = {556--562},
  doi = {10.1007/s11096-008-9209-4}
}
Kostenlos starten →